Details for New Drug Application (NDA): 203643
✉ Email this page to a colleague
The generic ingredient in GABAPENTIN is gabapentin. There are twenty-nine drug master file entries for this compound. Seventy-six suppliers are listed for this compound. Additional details are available on the gabapentin profile page.
Summary for 203643
Tradename: | GABAPENTIN |
Applicant: | Incepta Pharms Ltd |
Ingredient: | gabapentin |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Sep 9, 2024 | TE: | AB2 | RLD: | No |
Complete Access Available with Subscription